Sg Americas Securities, LLC Compugen LTD Transaction History

Sg Americas Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$0.66 - $2.32 $80 - $283	122 Added 0.32%	38,056 $25,000
Q2 2022 Jul 29, 2022	SELL	$1.57 - $3.33 $9,608 - $20,379	-6,120 Reduced 13.89%	37,934 $70,000
Q1 2022 Apr 29, 2022	BUY	$2.76 - $4.64 $121,589 - $204,410	44,054 New	44,054 $142,000
Q1 2021 May 13, 2021	SELL	$7.67 - $13.77 $274,148 - $492,181	-35,743 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$12.07 - $17.95 $292,057 - $434,336	24,197 Added 209.57%	35,743 $433,000
Q3 2020 Nov 09, 2020	BUY	$14.16 - $19.45 $21,848 - $30,011	1,543 Added 15.43%	11,546 $188,000
Q2 2020 Jul 20, 2020	BUY	$6.97 - $17.12 $69,720 - $171,251	10,003 New	10,003 $150,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.